Catalyst Wire Dossier Catalyst Wire Dossier

Ingenol Mebutate Gel, 0.015%

ingenol mebutate · LEO Pharma
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Ingenol Mebutate Gel, 0.015%, covering 2013-12-31 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp [Phase 4]

See pricing